Dr Philip Brown Head of Technology Transfer
Phil is responsible for overseeing the commercialisation of research outcomes for the University and industry collaborators.
Phil is responsible for overseeing the Technology Transfer team. They will work with you to commercialise your research through:
- identifying the commercial value of your research
- protecting the intellectual property of your research
- working with industry to commercialise your research
- negotiating with licensees, investors and partners
Phil supports research commercialisation for life sciences at the University.
Phil's early career was spent developing DNA based diagnostics at the University of Cambridge and at a biotechnology company, Cytocell Ltd. Phil then moved into the commercial side of science working at PharmaVentures Ltd, a pharmaceutical business consultancy, and within the commercial team at Vectura Ltd. This was originally a Bath spin-out, focusing on drug delivery to the lungs.
He also spent time working for Esperante Ventures, undertaking commercial due diligence for biotechnology investments.
Phil has been at the Unversity of Bath for over eight years and has been part of the team that has formed Ceryx Medical Ltd, Gen3D Limited, 3UG Autonomous Systems and BLOC Laboratories. He is currently the University Director for both Ceryx Medical Ltd and BLOC Laboratories.
Phil holds a BSc in Biochemistry and Pharmacology and PhD in Molecular Biology, investigating drug and protein binding to DNA, from the University of Southampton, and an MBA from Oxford Brookes University.